These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 10960838)
1. The novel heterodinucleoside dimer 5-FdU-NOAC is a potent cytotoxic drug and a p53-independent inducer of apoptosis in the androgen-independent human prostate cancer cell lines PC-3 and DU-145. Cattaneo-Pangrazzi RM; Schott H; Schwendener RA Prostate; 2000 Sep; 45(1):8-18. PubMed ID: 10960838 [TBL] [Abstract][Full Text] [Related]
2. Cell-cycle arrest and p53-independent induction of apoptosis in vitro by the new anticancer drugs 5-FdUrd-P-FdCydOct and dCydPam-P-FdUrd in DU-145 human prostate cancer cells. Cattaneo-Pangrazzi RM; Schott H; Wunderli-Allenspach H; Rothen-Rutishauser B; Guenthert M; Schwendener RA J Cancer Res Clin Oncol; 2000 May; 126(5):247-56. PubMed ID: 10815759 [TBL] [Abstract][Full Text] [Related]
3. Induction of cell cycle-dependent cytotoxicity and apoptosis by new heterodinucleoside phosphate dimers of 5-fluorodeoxyuridine in PC-3 human prostate cancer cells. Cattaneo-Pangrazzi RM; Schott H; Wunderli-Allenspach H; Derighetti M; Schwendener RA Biochem Pharmacol; 2000 Dec; 60(12):1887-96. PubMed ID: 11108805 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity, cell-cycle perturbations and apoptosis in human tumor cells by lipophilic N4-alkyl-1-beta-D-arabinofuranosylcytosine derivatives and the new heteronucleoside phosphate dimer arabinocytidylyl-(5'-->5')-N4-octadecyl-1-beta-D-arabinofuranosylcytosi ne. Horber DH; Cattaneo-Pangrazzi RM; von Ballmoos P; Schott H; Ludwig PS; Eriksson S; Fichtner I; Schwendener RA J Cancer Res Clin Oncol; 2000 Jun; 126(6):311-9. PubMed ID: 10870640 [TBL] [Abstract][Full Text] [Related]
5. Increased cytotoxicity and decreased in vivo toxicity of FdUMP[10] relative to 5-FU. Liu J; Skradis A; Kolar C; Kolath J; Anderson J; Lawson T; Talmadge J; Gmeiner WH Nucleosides Nucleotides; 1999 Aug; 18(8):1789-802. PubMed ID: 10478484 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of butanoate, retinoate, and bis(2,2,2-trichloroethyl)phosphate derivatives of 5-fluoro-2'-deoxyuridine and 2',5-difluoro-2'-deoxyuridine as potential dual action anticancer prodrugs. Xia Z; Wiebe LI; Miller GG; Knaus EE Arch Pharm (Weinheim); 1999 Aug; 332(8):286-94. PubMed ID: 10489539 [TBL] [Abstract][Full Text] [Related]
7. Z-1,1-Dichloro-2,3-diphenylcyclopropanes block human prostate carcinoma cell proliferation, inhibit prostate-specific antigen expression, and initiate apoptosis. Balachandran R; Grant SG; Welsh MJ; Day BW Prostate; 2000 Dec; 45(4):277-88. PubMed ID: 11102952 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxic effects of N-(3-chloro-1,4-dioxo 1,4-dihydro-naphthalen-2-yl)-benzamide on androgen-dependent and -independent prostate cancer cell lines. Kanaan YM; White DF; Das JR; Berhe S; Bakare O; Kenguele H; Beyene D; Zhou Y; Day AA; Copeland RL Anticancer Res; 2010 Feb; 30(2):519-27. PubMed ID: 20332464 [TBL] [Abstract][Full Text] [Related]
9. Synthetic retinoid CD437 induces S-phase arrest and apoptosis in human prostate cancer cells LNCaP and PC-3. Liang JY; Fontana JA; Rao JN; Ordonez JV; Dawson MI; Shroot B; Wilber JF; Feng P Prostate; 1999 Feb; 38(3):228-36. PubMed ID: 10068347 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and anticancer activities of amphiphilic 5-fluoro-2'-deoxyuridylic acid prodrugs. Ludwig PS; Schwendener RA; Schott H Eur J Med Chem; 2005 May; 40(5):494-504. PubMed ID: 15893023 [TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of new duplex drugs linking 3'-C-ethynylcytidine and 5-fluor-2'-deoxyuridine against human melanoma cells. Schott S; Niessner H; Sinnberg T; Venturelli S; Berger A; Ikenberg K; Villanueva J; Meier F; Garbe C; Busch C Int J Cancer; 2012 Nov; 131(9):2165-74. PubMed ID: 22323315 [TBL] [Abstract][Full Text] [Related]
12. 5-FdUrd-araC heterodinucleoside re-establishes sensitivity in 5-FdUrd- and AraC-resistant MCF-7 breast cancer cells overexpressing ErbB2. Strasser S; Maier S; Leisser C; Saiko P; Madlener S; Bader Y; Bernhaus A; Gueorguieva M; Richter S; Mader RM; Wesierska-Gadek J; Schott H; Szekeres T; Fritzer-Szekeres M; Krupitza G Differentiation; 2006 Dec; 74(9-10):488-98. PubMed ID: 17177846 [TBL] [Abstract][Full Text] [Related]
14. Apoptosis of human prostate androgen-dependent and -independent carcinoma cells induced by an isopropanolic extract of black cohosh involves degradation of cytokeratin (CK) 18. Hostanska K; Nisslein T; Freudenstein J; Reichling J; Saller R Anticancer Res; 2005; 25(1A):139-47. PubMed ID: 15816531 [TBL] [Abstract][Full Text] [Related]
15. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells. Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of zinc on human prostatic carcinoma cell growth. Liang JY; Liu YY; Zou J; Franklin RB; Costello LC; Feng P Prostate; 1999 Aug; 40(3):200-7. PubMed ID: 10398282 [TBL] [Abstract][Full Text] [Related]
17. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Hsieh TC; Wu JM Exp Cell Res; 1999 May; 249(1):109-15. PubMed ID: 10328958 [TBL] [Abstract][Full Text] [Related]
18. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice. Suy S; Mitchell JB; Samuni A; Mueller S; Kasid U Cancer; 2005 Mar; 103(6):1302-13. PubMed ID: 15685617 [TBL] [Abstract][Full Text] [Related]
19. Effect of duplex drugs linking 2'-deoxy-5-fluorouridine (5-FdU) with 3'-C-ethynylcytidine (ECyd) on hepatoblastoma cell lines. Eicher C; Dewerth A; Ellerkamp V; Fuchs J; Schott S; Armeanu-Ebinger S Pediatr Surg Int; 2013 Feb; 29(2):121-7. PubMed ID: 23187893 [TBL] [Abstract][Full Text] [Related]
20. PC-SPES: a unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo . Kubota T; Hisatake J; Hisatake Y; Said JW; Chen SS; Holden S; Taguchi H; Koeffler HP Prostate; 2000 Feb; 42(3):163-71. PubMed ID: 10639186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]